ReviewFrontiers in immunology2026
Atorvastatin as a pleiotropic anticancer agent: mechanisms, evidence, and therapeutic repurposing potential.
Jiaqi Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ReviewFrontiers in immunology2026
Jiaqi Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.